Study: Clot-busting drug OK for stroke patients on mild anticoagulants

03/15/2013 | HealthDay News

Giving tissue plasminogen activator to patients suffering a stroke who have been taking aspirin or the blood thinner clopidogrel is not likely to cause fatal brain bleeding, a study published in the journal Academic Emergency Medicine found. Researchers examined data from more than 800 tPA-treated stroke patients and found no significant difference in the brain bleeding rate between patients who were taking aspirin or clopidogrel and those who were not taking either drug. The findings might not apply to patients taking warfarin, heparin, dabigatran or rivaroxaban, the researchers noted.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ